Dace Trence, MD

                                                                                                                      January  2018   



Dace Lilliana Trence, MD, FACE



              Place of Birth:              St. Paul, Minnesota

              Citizenship:              USA

              Address:               University of Washington Diabetes Care Center,

4245 Roosevelt Way NE, Seattle, WA. 98105



BS - Summa cum laude in Biochemistry and Microbiology, University of Minnesota, College of Biological Sciences, 1971-1973

MD - University of Minnesota Medical School, Minneapolis, Minnesota, 1973-1977




Internship - Northwestern Hospital, Minneapolis, Minnesota, 1977-1978

Internal Medicine Residency - Northwestern Hospital, Minneapolis, Minnesota, 1978-1980

Endocrine Fellowship - University of Minnesota, Minneapolis, Minnesota, 1980-1982

Certificate Program in Management for Physicians - Univ of St Thomas, Minneapolis, MN, 1996

Certification in Bone Densitometry Interpretation (ISCD), 2004




Director - Diabetes Care Center, University of Washington, 2002- current

Assistant Program Director for Education - Division of Metabolism, Endocrinology and Nutrition,  

         University of Washington 2005-2007

Endocrine Fellowship Director - University of Washington, 2007- current

Assistant Professor - Division of Metabolism, Endocrinology and Nutrition 2001-2006

Associate Professor of Medicine - Division of Metabolism, Endocrinology, and Nutrition,

          Department of Medicine, University of Washington, 2006- 2012

Professor of Medicine- Division of Metabolism, Endocrinology and Nutrition, 2013- current




Clinical Professor - Endocrine Division, Department of Medicine, University of Minnesota Hospitals, Minneapolis, MN, 1982-1997

Medical Advisor - Diabetes Advisory Group, Fairview Riverside Hospital, 1989-1991

Member - Executive Committee, Institutional Review Board, Fairview-University of Minnesota Medical Center, 1997

Chief - Department of Medicine, Fairview Riverside Medical Center, 1992

President - American Diabetes Association, Minnesota Affiliate, 1994-1995

Director - Institutional Review Board, Fairview Riverside Medical Center, Minneapolis, MN, 1994-1997

Endocrinologist - Group Health Inc. Minneapolis, MN, 1982-1997

Director - Lipid Clinic, Group Health Inc. HealthPartners, Minneapolis, MN, 1990-1997

Chief - Endocrine Division, Group Health Inc. HealthPartners, Minneapolis, MN, 1985-1997

Director - Lipid Clinic, Group Health of Puget Sound, Seattle, WA, 1998-2001

Chief of Endocrinology - Group Health of Puget Sound, Seattle, WA, 1997-2001

Chief of Medicine - Selected Specialties (Endocrinology, Gastroenterology, Infectious Disease, Pulmonary Departments), Group Health of Puget Sound, Seattle, WA, 1999-2001

Clinical Assistant Professor - Division of Endocrinology, Department of Medicine, University of Washington, Seattle, WA, 2000-2001

Associate Director - Diabetes Care Center, University of Washington Medical Center, Seattle, WA, 2001-2002

Director - Endocrine Days Institute, Seattle, WA 2006- 2016







Thomas Ives Award (first recipient) for compassionate and dedicated service to patients in association with sound knowledge of internal medicine, 1980

President's Award in recognition of outstanding performance in serving the members of Group Health Inc. Minnesota, 1987

Teaching Award (first recipient) in recognition of outstanding achievement and enthusiasm in the area of teaching, Group Health Inc. Minnesota, 1991

"Best Docs in Twin Cities" in endocrinology, 1995, 1997, 1999

Outstanding Medicine Specialist, Residency Teaching Program, Group Health of Puget Sound, Seattle, WA, 1999

Outstanding Clinical Endocrinologist- American Association of Clinical Endocrinologists- AACE 2014

“PRAISE” U of Washington Award 2014, 2015, 2016

John Seibel Award- American College of Endocrinology 2017




American Board of Internal Medicine - 1995

American Board of Endocrinology and Metabolism - 2009




Washington (active) - 35563

Minnesota (inactive) - 12441



American Diabetes Association (ADA), Minnesota Affiliate

President (elected), 1995-1996

Minnesota Legislative Affairs Committee

Minnesota Affiliate Research Review Committee

Business Planning Committee

Minnesota Affiliate Board, Member, 1992-1996

Minnesota Women Physicians Association

Minnesota Medical Association

Minneapolis Internist Society

American Diabetes Association, Professional Section

Endocrine Society

American Association of Clinical Endocrinologists (AACE)


            Board of Directors, (elected) 2005-2007, 2008-2010 

           AACE National Scientific Meeting Planning Committee - 2006, 2008, 2009, 2010, 2011,

                       2013, 2015, 2018

                Continuing Medical Education Committee - Chair 2002- 2014, Vice-Chair 2014-current

            National Scientific Meeting Co-chair - 2007

                Publications Committee member 2005-current, Chair 2013- current

           Guidelines for Publication Committee - 2007-2010, 2013

                Academic Relations Committee - 2005-2006

                Educational Initiatives Committee - 2006-2008

                Diabetes Council - 2008- current

                Health Disparities Committee - 2010-2013

                Patient Safety Committee- Co-Chair- 2011-2012

            Nutrition Scientific Committee 2010-current, Chair 2015- current

            Endocrine Training Support Committee 2010-2013

            Endocrine University Committee- 2012- 2013

            Education Council- 2013- current

            Women in Endocrinology Task Force 2016- current

            APDEM_AACE Task Force- Chair 2015- current

             Empower Magazine editor- 2010- current

  ACE Empower Committee- Chair 2015-current

  AACE Pacific Northwest Chapter- Chair- 2014- current

  American College of Endocrinology (ACE)

Trustee 2007-2008

                Advisor- 2010-current

Fellowship (FACE) Application Committee, member 2011- current, Chair - 2012-2014,

Empower committee Chair 2015-current

AACE Fellow’s Travel Grant Committee 2016-current

  Association of Program Directors in Endocrine and Metabolism

            Council member (elected)  2011-2013

            Nominating committee 2017-2018

American Diabetes  Association Annual Program Technology Subcommittee 2017-2018


Health Monitor Network- Endocrinology /AACE liaison 2015-2017

Web-MD Advisory Board- 2016-current

Teaching responsibilities:


Endocrine Core Course (HuBio 556) small group discussion

1999 - dyslipidemia treatment

2000 - diabetes complications, dyslipidemia treatment

2001, 2002 - diabetes complications, osteoporosis

2003- diabetes complications, Cushing's syndrome

2004 - diabetes complications

2005 - congenital adrenal hyperplasia

2006 - ADH and water, diabetes complications

2007 - hypocalcemia, diabetes mellitus therapy

2008 - diabetes mellitus complications

Nutrition Core Course (HuBio 568)

2004- obtaining nutrition history in diabetes mellitus

2005- small group session: nutrition in diabetes mellitus

Med 533 course: Diabetes Mellitus Type 1 lecturer 2009-2013

Hormones and Nutrients Core Course (HuBio 556) - small group discussion leader

2010 - Vitamin D, Low Bone Density in Elderly, Nutrition and DM type 1

2011 - Diabetes mellitus complications

Diabetes mellitus - a review: Nurse Practitioner degree program. Seattle-Pacific University, February 2001

NURS 510 Pathophysiology of diabetes mellitus, Nov 2003, August 2003, July 2004, Nov 2004,

Endocrine Teaching Conference: 

Diabetes Practicalities May, 2006

Summer series: Pituitary Disease Review August, 2006

Journal Club. January, 2007, October 2009, October 2010,October 2011, November

      2012, October 2013, October 2014, October 2015, October 2016, November 2017

Summer series: Pituitary Disease Review August 2007

              Retinopathy/ neuropathy/ nephropathy April 2008

              Insulin Pumps 101 for fellows January 2009, August 2013, August 2016

Insulin Pumps: Who, What, How October 2009

              Oral glycemic agents   October 2009

            CGMS and glucose meter data interpretation October 2012

            Board Review Questions November 2015, January 2016, January 2017 (2 sessions),         

                        October 2017, November 2017

            Initiating Insulin October 2015

            Diabetes Drugs- Infinite Choices December 2016, November 2017

Rehab 496 - Diabetes and Disability lecturer March, 2009, 2012, September 2013

Lab M 685 - Lab Medicine (Diabetes) lecturer - 2008, 2010, 2013, 2015, 2016. 2017. 2018  

Diabetes for Psychiatry fellows in training February 2011

Diabetes Update for Residents Harborview October 2012

NWGEC (Northwest Geriatrics Healthcare Conference) Diabetes Type 1 in the Elderly UWMC.

            April 2015 



Specific Teaching Encounters with residents and students:

Internal medicine resident, medical student rotations:

Diabetes Care Center rotations (3 residents 2007-2008, 3 residents 2008-09, 3 students 2007-2008, 2 students 2008-09, 4 students 2009-2010, 5 internal medicine residents 2009-2010, 6 students 2010-2011, 6 residents 2010-2011, 10 residents 2012-2013, 8 residents 2014-2015)

Endocrine fellow diabetes continuity clinic attending (8 fellows 2008-2009, 10 fellows 2009-2010, 11 fellows 2010-2011, 10 fellows 2011-2012 ,9 fellows 2011-2013, 9 fellows 2014-2015, 10 fellows 2015-16, 10 fellows 2016-17, 8 fellows 2017-18)

Endocrine fellow diabetes clinic subspecialty rotation (4 fellows 2009-2010, 3 fellows 2010-2011, 3 fellows 2011-2012, 4 fellows 2012-2013, 4 fellows 2014-2015, 3 fellows 2015-16,4 fellows 2016-17, 2 fellows 2017-18 )

UW Physician Assistant program- Winter quarter 2017, winter quarter 2018


General Teaching Responsibilities:

Internal Medicine G2 and G3 preceptorship in community Endocrinology at Group Health 1997-2001

Family Practice G2 and G3 resident preceptorship in Endocrinology at Group Health 1997-2001

Endocrine fellows preceptorship in Diabetes Care Center one to 1 1/2 days per week

Internal Medicine G2 and G3 resident preceptorship in Diabetes Care Clinic one to two half days per week

Endocrinology Clinic attending first, second and third Mondays of each month, preceptorship for endocrine fellows, residents in internal medicine, OB/gynecology, and medical students on endocrine rotation

Medical student preceptorship in Diabetes Care Clinic one to 2 half days per week one month per year

Inpatient hospital endocrine consult service attending November 2017, December 2017, December 2016, December 2015,November 2014, January 2014, April 2013, January 2013, December 2012, 2011,2010, 2009, April 2009, March 2008, November 2006, March 2006, 2005, January 2004, April and December 2002



CME (invited):

Diabetes mellitus- review of recent advances in medical care.  CME grand rounds, Harrison Hospital. Bremerton, WA, October 2001

Use of oral glycemic agents - a bit of science, sense and speculation.  Redding Medical Center, Redding, CA, March 2002

Update of the treatment of type 1 diabetes. CME grand rounds, St. Mary's Hospital, Walla-Walla, WA, May 2002

Definitions of insulin.  Treatment of diabetes in special populations (two presentations), University of Washington, May 2002

Evidence based medicine support for standards of care in treatment of diabetes mellitus. Prevention of diabetes 2002 (two presentations), Northwestern Hospital. Seattle, WA, May 2002

Update in Diabetes Mellitus.  ACP Board Review.  Seattle, WA, July 2002

Current Insulin Strategies.  CME grand rounds, Madigan Hospital, Fort Lewis, WA, August 2002

Advances in Family Practice and Primary Care - Endocrinology work-shop. U of Washington, Seattle, WA, September 2002, 2001

Treatment of Type 1 and Type 2 diabetes in 2002.  CME three hour course presentation and workshop Yakima, WA, October 2002

Travel and International Medicine - 10th Annual Update.  University of Washington, Seattle, WA.  Workshop:  Travelers with Chronic Illness or When the Unwell go Abroad, April 2003

Endocrine case workshop.  Family practice annual review course, UW, Seattle, WA, September 2003

Diabetes management-CADRE.  AACE sponsored. Tacoma, WA, November 2003

Current insulin strategies, Silverdale, WA, November 2003

Diabetes and Disability. Occupational/Physical Therapy Review Course. UW, Seattle, WA, April 2004

Nutrition in the ICU. Endocrine Days, Seattle, WA, May 2004

Physiologic Insulin Use. Grand rounds Madigan Hospital, Tacoma,WA, August 2004

Endocrine Disorders- Case Workshop. Advances in Family Practice and Primary Care.UW, Seattle. September 2004

Physiologic Insulin Use- Case Management. Washington Association of Diabetes Educators. Spokane, WA, October 2004

Physiologic Insulin Use.  Washington State Pharmacy Association, Spokane, WA, October 2004

Physiologic Insulin Use- Case Management.  Washington Association of Diabetes Educators, Seattle, WA, January 2005

Treatment of Diabetes in Financially Limited Populations.  Tacoma, WA and Seattle, WA, June 2005

Diabetes Mellitus- New Treatments. Grand Rounds, Kadlec Hospital, Richland, WA October, 2005

Diabetes Mellitus- New Treatments, Current and Future. Grand Rounds, U of Washington, January, 2006.

Nutrition Tutorial. U of Washington RDs. February, 2006

Diabetes Mellitus- Update for Primary are. (CME course co-director)U of Washington, March, 2006: Incretin use in diabetes, Diabetes in the news, Stump the experts

Diabetes- What's New in Laboratory Testing, U of Washington. March 2006

Diabetes and Disability. UW, May, 2006.

Needles, Pens and Inhalers. Washington Academy of Family Practice, Semiahmoo, WA, May, 2006.

Insulin in Diabetes Mellitus. Bastyr University, Seattle, Washington, July 2006

Endocrine workshop. UW- Family Practice yearly update, Seattle, WA, September, 2006

Endocrine Update. Washington Association of Physician Assistants. SeaTac, WA January, 2007

Targeting Non-HDL Cholesterol AACE Annual Meeting, Seattle, WA April 2007

Laboratory Review in Diabetes Mellitus. UW, Seattle, WA, April, 2007

Diabetes 2007- Grand Rounds Good Samaritan Hospital, Puyallup, WA, April, 2007

Diabetes Update. International Comparative Physiology Scientific Sessions. Vancouver, BC, June, 2007

Pay for Performance. American Diabetes Association Plenary session. Chicago, IL, June 2007.

PNW Renal Days- What's New. UW September, 2007, Seattle

Heart failure and Diabetes. Women and Heart Disease Symposium.Boston, Mass, October, 2007

Diabetic Autonomic Neuropathy. Endcorine Days. Vancouver, BC January, 2008

Diabetes and Oral Agents 2008- Boise, ID, January 2008 ( two grand rounds)

Diabetes Treatment Update and Challenging Diabetes Cases, (two presentations) Diabetes Egyptian Endocrine Society,  Alexandria, Egypt, April 2008

Oral Hypoglycemic Agents. Adult / Geriatric Drug Therapy UW CME course Lynnwood, WA, April, 2008

Diabetes 2008- What Have we Learned in the Past Year, Complimentary Medicine in Diabetes (two presentations)  Idaho Medical Association Meeting, Sun Valley, Idaho, August 2008; Tight Control in Diabetes- Vindicated.  Growth Hormone Use in Metabolic Syndrome - Not Ready for Prime Time (two presentations) Endocrine Days. Stevenson, WA, October, 2008

Endocrine Cases for the Primary Care Provider. Annual National Conference in Advanced Practice. Seattle, WA, October, 2008

The Lab in Diabetes. UW Lab Medicine Course, Seattle, WA, November 2008

Diabetes Guidelines. Providence Hospital (Cherry Hill) Grand Rounds. Seattle, WA, April, 2009

Old Friends, New Friends- Oral glycemic drugs in Diabetes- UW Hospital Grand Rounds - Seattle, WA. April, 2009

Oral Diabetes Medications. Drugs in Medicine UW CME Course. May, 2009

Injectable Medications in Diabetes Treatment. Drugs in Medicine UW CME Course. May 2009

Optimizing Diabetes Care: Successful Clinical Strategies. Endocrine Society/Med IQ:  Denver, CO, July 2009; Kansas City, KS, July 2009; Wichita, KS, July 2009; Des Moines, IA, July 2009; Milwaukee, WI, August 2009

Endocrine Case Studies. 37th Annual Advances in Family Practice and Primary Care. UW, Seattle, WA, September 2009

Use of FRAX in Osteoporosis. Advanced Practice in Primary & Acute Care 2009-Pacific Northwest 32nd Annual National Conference. Seattle, WA, October, 2009

A1c- Tempest in a Teapot UW Diabetes CME course Seattle, WA, October, 2009

Does Glucose Control Really Matter. Kadlec Hospital grand Rounds, Richland, WA November, 2009

Diabetes Complications- a 2010 Update. 26th Annual CME Seminar. Kennewick, WA, February 2010

Intensifying Insulin Therapies. Evergreen Diabetes Conference. Kirkland, WA, March, 2010

Diabetes Markers- an Update. Endocrine Days. Seattle, WA, April, 2010

Diabetes for Primary Care- Joslin CME- Denver, CO, June 2010

Endocrine Case Studies. 38th Annual Advances in Family Practice and Primary Care. UW, Seattle, WA, September 2010

Test Your Expertise- MOC. Endocrine Days. Seattle, WA  October 2010

Management of Diabetes- Basics.  Kaiser Permanente CME. Vancouver, WA January 2010

Genetics in the Everyday World of Diabetes. Endocrine Days. February, 2011

Management of Diabetes- Case Studies Kaiser Permanente CME. Portland, OR March 2011

Diabetes and Renal Disease, Case Presentation- Monograph- Endocrine News- Spring 2011

Diabetes and Renal Disease, Case Presentation- webcast- Internal Medicine News- Spring-Winter 2011

SMBG- webcast- Present Diabetes- Spring 2011

Diabetes Update- Diagnosis, Management. Northwest Optometrists Woodinville, WA, May 2011

Meet the Professor- CGMS Endocrine Society Boston June 2011

Endocrine Case Studies. 39th Annual Advances in Family Practice and Primary Care. UW, Seattle, WA, September 2011

Blood Glucose Monitoring in Type 2 Diabetes. In :Living Medical eTextbook Eds: A Garber. Endocrine Society/Projects in Knowledge. (web-based) Winter 2011

Pursuing Type 2 Diabetes Treatment Goals Among In-Plan Clinicians and Covered Patients: Payor Strategies for Optimizing Outcomes. NAACME. Webinar. November, 2011

Intensification of Diabetes Mellitus Management-Barriers to Insulin. Horizon CME. November 2011-slide preparation (locations to be determined)

Non-Insulin Therapies for the Treatment of Diabetes. Diabetes Update for Primary Care Providers. UW CME February, 2012

Case Studies: Non-Insulin Therapies for the Treatment of Diabetes. Diabetes Update for Primary Care Providers. UW CME February, 2012

Diabetes Mellitus-a 2012 Update. 28th Annual CME Seminar. Kennewick, WA, February 2012

Management of Diabetes Mellitus-Update. Pri-Med Houston March 2012, Anaheim April 2012, Chicago May 2012, Houston March 2013, San Francisco June 2013, Cleveland October 2013, Chicago October 2013, New York November 2013

Management of Diabetes AAFP Annual Scientific Congress  San Diego, September 2013

Management of Diabetes Cardiometabolic Congress Las Vegas 2013

“What’s New in the Frying Pan”- review of statin controversies ARNP Regional Conference Seattle, October 2013

Non-injectable diabetes medication, Hands-on Workshop (2 presentations UWMC CME January 2014)

Management of Diabetes Mellitus-Update. Pri-Med Princeton September, 2014

Hypoglycemia  Med-IQ: Anaheim October, 2014, Philadelphia November, 2014, Cleveland        

                             November, 2014

Hypoglycemia in the Hospitalized Patient. Perioperative Medicine Summit, Phoenix, February 2015

Diabetes Day for Primary Care. AACE February 2015, moderator, speaker (Diabetes Guidelines, Cardiovascular Risk Factors and Diabetes, Patient Case)

Update of Data from DPP and Look Ahead- WADE- Seattle, March, 2015

GLP-1 RA and Diabetes Mellitus, Type 2. Med-IQ. Houston March 2015, Long Beach May 2015, San Jose August  2015, New York November 2015   

Update of Treatments in Diabetes Mellitus, Type 2, OHSU, Ashland, Oregon,  August, 2015

Alaska Native Diabetes Conference (2 presentations) Hypoglycemia, Initiating Insulin December 2015

GLP-1 and Diabetes Mellitus Type 2 (live webinar) Boston September 2015, Boston January 2016

Diabetes Day for Primary Care AACE Portland, Oregon February 2016

Diabetes for Primary Care UWMC Seattle, WA March 2016

Benton-Franklin County Medical Society Annual CME Seminar. Pre-diabetes and the Prevention of Type 2 Diabetes. Kennewick, WA March, 2016

Examining the Role of Long-Acting Insulins in Diabetes Mellitus. Cardiometabolic Conference

           New Orleans March 2016, Las Vegas October 2016

Medication Update in Diabetes- Old and New Drugs revisited WAPA Seatac April 2016

Initiating Insulin Bastyr Seattle April 2016

Endocrine Skills Summit “Glucose Meter Downloads”, “Pumps and Sensors”, “GLP-1 RA and Insulin” “Diabetes 2016 and into the Future” AACE/Horizon, Chicago 2016

Role of New Long Acting Insulins AACE Pacific Northwest Chapter Seattle November 2016

GLP-1 RA and Insulin Pri-Med Scottsdale July 2016, New York November 2016 (also videotaped for CME on-line August 2016)

GLP-1 RA and Insulin Combination Pri-Med Ft Lauderdale February 2017, Anaheim May 2017, Houston June 2017, Seattle June 2017, Los Angeles October 2017, Chicago October 2017

Diabetes Update: New Drugs and Cardiovascular Outcome Trials UW Seattle, February 2017

Diabetes Technology Workshop AACE Annual Meeting Austin, Texas May 2017

Ultralong Basal Insulins  Pri-Med Philadelphia September 2017

Day for Diabetes- Boise- September 2017

AACE Pacific NW Chapter Annual Conference- moderator-  October 2017

Endocrine University- Rochester, MN- March 2018: Lecture: Hypoglycemia. Workshop: Diabetes Technology and Cases

Keynote address (2): Endocrine Conundrums, Diabetes Cases: Challenges Seatac, WA April 2018

Diabetes Technology AACE Annual Meeting May 2018

Nutrition Symposium AACE Annual Meeting May 2018




Invited lectures (non-CME):

Osteoporosis - a review.  Group Health, Everett, WA, January 2001

Control of hyperglycemia in steroid induced diabetes mellitus.  Transplant service in-service. U of Washington, Seattle, WA, May 2001

Treatment of diabetes in the hospitalized patient.  Medical resident noon lecture series ( three presentations total).  Harborview, Providence, Veteran's Administration Hospital, Seattle, WA, August 2001

Diabetes update for opthalmology residents.  U of Washington, Seattle, WA, November 2001

Primary adrenal insufficiency.  Chairman's rounds, U of Washington, Seattle, WA, September 2001

Care of diabetes mellitus in the older adult.( two presentations- one for MAs, one for RNs).  Foss Care Center.  Seattle, WA, January 2002

Diabetes- a review for residents in anesthesia.  U of Washington, Seattle, WA, June 2002

Treatment of thyroid disease.  Medical resident noon lecture series, Harborview, Seattle, WA, June 2002

Adrenal disease- diagnosis, treatment.  Medical resident noon lecture series.  Providence Hospital, Seattle, WA, August 2002 and Veteran's Hospital, Seattle, WA, August 2002

Treatment of diabetes mellitus in special populations-inservice. Neighborhood Clinics. Providence Hospital.  Seattle, WA, November 2002

Women's health initiative- where do we go from here?  Lecture for health providers, Seattle, WA, November 2002

Insulin replacement in type 1 and type 2 diabetes mellitus.  Current insulin strategies: a course for medical residents, Seattle, WA, November 2002

Complications of diabetes.  Chief resident lecture series, U of Washington, Seattle, WA, November 2002

Osteoporosis- Moving Beyond the WHI. Lecture for health providers. Bellevue. March 2003

CPC- Diabetic gastroparesis. Providence Hospital, March 2003

Diabetic ketoacidosis and hyperosmolar coma. Resident lecture. Providence Hospital March 2003, U of Washington March, 2003

Current and Future Trends in Diabetes Technology. Northwest Association of Cardiovascular and Pulmonary Rehabilitation, Seattle, April, 2003

Diabetes Mellitus- a review.  Portland, OR, May 2003; Seattle, WA, May 2003; Tacoma, WA, June 2003;

Polycystic Ovarian Syndrome.  Hall Health Core lecture, UW, April 2003

Insulin in the Older Individual.  Evergreen Consultant Pharmacists, Kirkland, WA, June 2003

Pathophysiology of diabetes. Nusing 510. UW course. Seattle. August, 2003. November 2003

Thyroid disorders. UW medical resident lecture, UW. July, 2003

Diabetes mellitus complications. UW medical resident lecture, UW, July 2003

Inpatient diabetes management. Medical resident noon lecture series. Providence Hospital, September 2003; VA Puget Sound, September 2003

Growth hormone use in adults- point/counterpoint.  Endocrine teaching conference, UW Seattle, WA, October, 2003

Endocrine emergencies.  Medical resident lecture series.  UW Seattle, WA, November 2003

Diabetes- treatment concepts targeting populations across ages.  Alaska Native Medical Center annual meeting, Anchorage, Alaska, December 2003

Diabetes- an update in glycemic and non-glycemic treatments.  Lecture for health care providers, Anchorage, Alaska, December 2003

Hyperosmolar, hyperglycemic syndrome.  UW Chairman's rounds, Seattle, WA, December 2003

Diabetes and disability. 2004 Conference on Medical Aspects of Disability. UW Seattle, WA, January 2004

Use of computer technology in the epidemic of diabetes mellitus- introduction. American Association for Advancement of Science annual meeting. Seattle, WA, February 2004

New concepts in the glycemic treatment of diabetes. Virginia Mason Hospital Endocrinology Division, Seattle, WA, March 2004

Insulin Use in Diabetes Mellitus-an Update.  Polyclinic grand rounds.  Seattle, WA, April 2004

Facets of complications associated with diabetes mellitus.  Noon resident lecture series, UW, Seattle, WA, July 2004

Insulin use in diabetes mellitus type 1 and 2- case management.  Lecture for primary care providers, Seattle, WA, July 2004

Diabetes Mellitus- a review.  Endocrine fellows summer lecture series, UW, Seattle, WA, August 2004

Pituitary disease- diagnosis and management.  Noon resident lecture series, UW, Seattle, WA, January 2005

Osteoprosis- targeting therapy to the patient.  Albuquerque, NM, July 2005; Tacoma, WA, June 2005; Brookings, OR, May 2005

Insulin use in the inpatient setting.  Noon resident lecture series, UW, Providence Hospital, Seattle, WA, May 2005

Intensive treatment of diabetes mellitus- case presentations.  Polyclinic grand rounds, Seattle, WA, July 2005

Early use of insulin in diabetes. Seattle, WA, November. 2005.

Adrenal disease noon resident lecture. Providence-Swedish, Seattle, March, 2006, New Treatments in Diabetes Providence-Swedish, November, 2006.

Osteoporosis- An update. Billings, Montana, May, 2006.

Post-fracture Intervention. Seattle, WA, September, 2006, Bow, WA November, 2006.

Incretin Therapy. Port Orchard, WA October, 2006, Seattle, WA, November, 2006, Olympia, WA, November, 2006.

Endocrine Emergencies. UW, Seattle, WA, January 2007.

Oral Hypoglycemic Agents, Everett, Washington, January, 2007

Oral Hypoglycemic Agents, Swedish Hospital Pharmacists, Seattle, February 2007

Glucose in the ICU. Everett Hospital. Everett, WA March 2008

Sensors- Current Use and Reimbursement Dilemnas. AACE Socioeconomics Meeting. Minneapolis, MN, August 2008

Hyperparathyroidism. Medicine Chairman's Rounds. UW, Seattle, September, 2008

Insulin Replacement in Type 1  and Type 2 Diabetes. American Lake VA Rounds. Lakewood, WA, December 2008.

Grave's Hyperthyroidism.  Department of Medicine Chairman's Rounds UW Hospital, Seattle, WA, December 2009

Board Review Questions- Calcium (October 2011) Diabetes Mellitus, Part 1. (November 2011)Endocrine Teaching Conference. UW-Seattle.

Oral Hypoglycemic Agents in Diabetes Mellitus. Endocrine Teaching Conference UW-Seattle. December, 2011

Diabetes for the Primary Care Physician Tacoma, WA, January, 2011

Starting Insulin in Diabetes Mellitus Type 2 Harborview Internal Medicine Resident Rounds. Harborview. Seattle. November, 2011

Starting Insulin in the Patient with Type 2 Diabetes Mellitus, UW Internal Medicine Resident Rounds. UW Seattle, WA November, 2011

Diabetes Education – Does it Matter?  What can you teach in one minute.  Roosevelt Grand Rounds, Seattle March 2012

Lab Medicine, UW 685 – Diabetes (lecture), Seattle May 2012ee

Newly Diagnosed with DM2- what to do. Roosevelt Grand Rounds February 2014

Endocrine Teaching Conference:  CGM and Meter Data Interpretation in Diabetes Mellitus September 2014, Oral Hypoglycemic Agents October 2014, Board Review Questions November 2014, December 2014

Internal Medicine Resident Noon Conference “Insulin Initiation in Diabetes”  UWMC

                             October, 2014 




Community presentations:

Get active with diabetes.  Healthy U(niversity of Washington). REI, Seattle, WA, March 2001

HMOs and diabetes- how to get the care you need. Take Control of your Diabetes.  Convention Center, Seattle, WA, April 2001

HRT and menopause.  Diabetes Prevention Program lecture series.  Veteran's Administration Hospital, Seattle, WA, September 2001

Diabetes mellitus- what's new in type 1.  Families with children with diabetes.  Group Health, Lynnwood, WA, October 2001

Diabetes update.  Community diabetes support group.  Steven's Hospital, Seattle, WA, May 2002

What's new in diabetes, 2002.  Diabetes Day, Harborview Hospital, Seattle, WA, June 2002

Question and answer session.  Families with children with diabetes support group.  Group Health. Lynnwood, WA, November 2002

Cardiovascular disease and diabetes mellitus.  Look Ahead Study support group.  Veteran's Administration Hospital, Seattle, WA, February 2003

Diabetes treatment - team approach.  Families with children with diabetes support group.  Group Health, Lynnwood, WA, March 2003

Diabetes- what is it, how to treat, the future.  Seattle Southeast Community Center, Seattle, WA, April 2003

Diabetes 2003.  Boeing retirees group "Blue Bills", Seattle, WA, June 2003

Supplements in diabetes care-what is the science?  Look Ahead study participant group.  VA Puget Sound, Seattle, WA, July 2003

Fireworks and fizzles- what's new in diabetes.  Harborview Medical Center Diabetes Day. Seattle, WA, August 2003

Advances in diabetes mellitus, 2004.  Juvenile Diabetes Research Foundation.  Science Museum, Seattle, WA, October, 2004

Women in diabetes.  Presentation and discussion group for women involved in the care of patients with diabetes.  Seattle, WA, December 2004

Diabetes complications and their prevention.  Marshallese Independence Day Celebration.  Everett, WA, May 2005

Fireworks and Fizzles- what's new in diabetes in 2005. Harborview Medical Center, Seattle. June 2005

Inflammation and cardiovascular disease in diabetes.  Veterans' Administration Hospital, Seattle, WA, July 2005

Diabetes and heart disease. Hall Health, Seattle, February, 2006

Diabetes complications. VA Puget Sound, Seattle, April, July 2006.

Update in diabetes. Diabetes Day. Harborview Hospital, Seattle, WA June, 2006

Thyroid Cancer Information for Patients and Family symposium participant. AACE Annual Meeting, April, 2007

Neuropathy, What's new? Diabetes Expo- Seattle, WA, April, 2007

Osteoporosis- Update, Juanita, WA, August, 2007

Diabetes, Type 1. Mini-Medical School, Boise, Idaho January, 2008

Diabetes Update, Stevens Hospital Lynnwood, WA, November, 2010

Diabetes Management- Case Based Panel Discussion- Bastyr  November 2012

Diabetes- an Update Lynnwood, September 2014

Update in Type 1 Diabetes UW Diabetes Care Center June 2015

Diabetes: New and Better Tools for 2016 and beyond  Trilogy- Osher Redmond September 2016

Diabetes and You- T1 DM conference- Kitsap Peninsula June 2018


Editorial responsibilities:

Editorial Board, Group Health Utilization Review 1993-1997

Editorial Board, Postgraduate Medicine 1993- 2005

Editorial Board, Clinical Diabetes 2000- 2002

Editorial Board EndoText, 2006-current

Editor, Empower magazine-AACE sponsored for lay audience targeting endocrine related issues 2012- current




Contributor, questions in Endocrinology for Internal Medicine Boards, 2001, 2002

Reviewer, questions in Endocrinology for Internal Medicine Boards, 2000, 2001, 2002, 2003, 2004

Reviewer of manuscripts for:  JCEM 2004; JAMA 2003, 2004; J of Managed Care 2002; Endocrine Practice 2002, 2004, 2011, J of Behavioral Medicine 2011

Coordinator of symposium for American Association for Advancement of Science national meeting, "Use of Computer Technology in the Epidemic of Diabetes Mellitus," February 2004

CME - update for AACE chapter chairs.  AACE National Scientific Meeting, Boston, April 2004

CME and new ACCME guidelines.  AACE Board meeting, Houston, November 2004

CME Update-AACE CME instituted changes in response to new ACCME (Accreditation Council for Continuing Medical Education) guidelines.  Corporate Advisory Panel - AACE Board Meeting, Amelia Island, January 2005

Presenter: Continuing medical education (CME) new rules and regulations.  AACE chapter chair meeting National Scientific Meeting, Washington, DC, May 2005

Co-chair AACE National Scientific Program, Seattle, WA 2007

AHRQ panel member for prevention quality indicators project in diabetes mellitus- 2009

Writer of questions for new (in development) Obesity Medicine Physician Certification 2009-2010

Contributor to AACE national publication for patients- "Obesity" - Complications associated with obesity- released February 2010

Co-editor AACE national publication for patients "Diabetes" Spring 2010

Writer board questions for newly formed certification boards in Obesity Fall 2010

Moderator Endo Society Advances in Diabetes Mellitus, Houston 2012

Co-editor AACE Power of Prevention./ EmPower Journal that is distributed to all endocrinologists that are AACE members and will go out to primary care offices as of 2010-2012

Invited editor Research to Practice” section: Glycemic Variability for August 2012 “Diabetes Spectrum” issue

Editor AACE Empower magazine 2012

Invited representative to ABIM Subspecialty Society (representing AACE) review meeting February 2013

Invited Beta-tester for Boards in Endocrine and Metabolism 2013, 2015, 2016

Invited update e-text Endocrine- Endo Society- 2013

Abstract reviewer Scientific Sessions AACE 2013, ADA 2013, Endo Society 2018, AACE 2018, ADA 2018

Co-Chair Endocrine Skills Summit CME Chicago October 2016

Chair Annual Meeting AACE Pacific Northwest Chapter November 2016, 2017



Special local responsibilities:

Co-director of Seattle program "Taking Control of your Diabetes", April 2001, May 2002 (also presenter in 2001, 1999, 1998)

Coordinator, UW Endocrine Teaching Conference, 2003- current

Reviewer for Washington State Health Care Authority Technology Assessment: Glucose Monitoring:- Self Monitoring in Patients Under 18 Years Old HTA” 2011

Chair Endocrine Days Institute Board 2005-2015

Chair of UW Primary Care/ Diabetes Specialty Task Force for collaborative specialty-primary care development system, in support of Center of Excellence

Coordinator UW DCC- Pacific Science Center Research Weekend 2012- presenting research in diabetes done at the University of Washington

Co-Chair AACE Pacific Northwest AACE Chapter 2014-2015, now Chair-current





E. Wagner (PI)  ID #035678 10/2000-5/2003  Robert Wood Johnson Foundation "Technical assistance and directions for improving chronic illness care"- study to improve care of patients with diabetes by medicine residents and nurse practitioners. (completed)


D Trence (PI- Seattle)   5U01DK057131  9/1999-8/2006 National Institutes of Diabetes, Digestive and Kidney Diseases "Study of outcomes of weight loss (Look Ahead Study) -study to investigate longterm health effects of weight loss in patients with diabetes type 2, who are overweight.(completed)


J. Palmer (PI)  Randomized, double-blinded, placebo-controlled, prallel-group study to investigate the safety and tolerability as well as the immunological and clinical efficacy of multiple subcutaneous doses of DIA-PEP 277 in LADA subjects. GAD antibody screening consent.(completed)


W. Hagopian (PI)  Predicting insulin dependent diabetes in the general population.


I DeBoer (PI) Hypoglycemia in Diabetes Type 2 Patients with Chronic Kidney Disease ADA


I DeBoer (PI) Preventing Early Renal Loss in Diabetes NIDDK/JDRF NCT02017171







D. Trence (PI)  52 week, multinational,multi-center, open-labeled, randomized, two-group parallel trial comparing efficiacy and safety of insulin detemir and insulin glargine as add-on to current oral antidiabetic drugs in subjects with type 2 diabetes. (completed)


G. Bond (PI)  Use of computer based medical care directive in treatment of diabetes in the elderly (completed).


I. Hirsch (PI)  Efficacy and safety of inhaled technosphereTM/Insulin compared to technosphere/Placebo in patients with type 2 diabetes mellitus following diabetes education (completed).


I. Hirsch (PI)  Efficacy and safety of inhaled technosphereTM/Insulin compared to routine insulin injection in patients with type 1 diabetes mellitus.( completed)


L Harris (PI) Clinical Trial to Test the Effectiveness of Video Games to Improve Glycemic Control In Diabetes. ( completed)


D. Trence (PI) Acceptibility of CONTOUR Blood Glucose Monitoring System with High Frequency Testing Patients ( completed)


D Trence (PI)  26 Week Randomized, Confirmatory, Controlled, Open-label, Multicentre. Multinational Treat-to-Target trial Comparing the efficacy and Safety of SIBA 200U/ml Three Times Weekly Injected in the Evening and insulin Glargine Once Daily in a Population of Insulin Anive Subjects with Type 2 Diabetes Mellitus Currently Treated with OADs Qualifying for Intensified Treatment  (completed)


D Trence (PI)  A Phase II, Randomized, Double Blind, 2 Way Crossover Safety and Efficacy Study of Subcutaneously Injected Prandial Insulins: Lispro-PH20 or Aspart-PH20 Compared to

Insulin Lispro (Humalog) in Patients with Type 2 Diabetes(completed)


Amtmann D (PI) Pain Assessment- Neuropathy in Diabetes Mellitus. NIH sponsored. (Completed 2012)


D Trence (PI-Seattle site) ACTION for Health in Diabetes (Look Ahead). NIH Sponsored-completed 2015


D Trence (PI-Seattle site) Diabetes Prevention Program Outcomes Study (DPPOS) NIH sponsored-completed 2015


D Trence (co-PI) Glycemia Reduction Approaches for Diabetes Effectiveness (GRADE) NIH Sponsored.-competed 2015



1)              Trence DL, Khan MY, Gerding D:  Beta-hemolytic streptococcal bacteremia in adults: association with cold weather in Minnesota.  Minn Med 64:675-679, 1981.

2)              Schwartz HL, Trence DL, Oppenheimer JH,et al:  Distribution and metabolism of L- and D-triiodo-thyronine (T3) in the rat: preferential accumulation of L-T3 by hepatic and cardiac nuclei as a probable explanation of the differential biological potency of T3 enantiomers.  Endocrinology 113:1236-1243, 1983.

3)              Slag MF, Morley JE, Elson MK, Trence DL, et al:  Impotence in medical clinic outpatients. JAMA 249:1736-1740, 1983.

4)              Trence DL. Thyroid replacement therapy.  Postgrad Med 73:367, 1983.

5)              Trence DL, Morley JE, Handwenger BS:  Polyglandular autoimmune syndromes.  Am J Med 77:107-116, 1983.

6)              O'Connor PJ, Rush WA, Trence DL Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintanence organization.  J Fam Pract 44:462-467, 1997.

7)              Trence DL:  Options for treating morbid obesity.  Postgrad Med 105:40-41, 1999.

8)              Trence DL:  Use of an insulin pump in an adolescent.  Clinical Diabetes 18:181-182, 2000.

9)              Trence DL, Hirsch IB:  Hyperglycemic crises in type 2 diabetes mellitus.  Endocrinol Metab Clin North Am 30:817-831, 2001.

10)              Trence DL:  Peripheral neuropathy in diabetes: is it diabetic neuropathy?  Clinical Diabetes 20:103-104, 2002.

11)              Trence DL:  Management of patients on chronic glucocorticoid therapy - an endocrine perspective.  Prim Care Clin Office Prac 30:593-605, 2003.

12)              Maliq T, Trence DL:  Treating diabetes using oral agents.  Prim Care Clin Office Prac 30:527-541, 2003.

13)              Trence DL:  Diabetes and neuropathy - is it diabetic neuropathy.  Diabetes Forecast, June 2003.

*14)              Trence DL, Kelly JL, Hirsch IB:  Treatment of the hospitalized patient with diabetes - time for change.  J Clin Endocrinol Metab 88:2430-2437, 2003.

15)              Trence DL: Neuropathy. Diabetes isn't always to blame. Diabetes Forecast. 56:107-9, 2003.

16)              Chiu, H, TrenceDL:  Diabetic neuropathy, the great masquerader: truncal neuropathy Manifesting as abdominal pseudohernia. Endocr Pract.12:281-3, 2006. 

17)              Utzschneider KM, Trence DL: Effectiveness of gastric bypass surgery in a patient with familial partial lipodystrophy. Diabetes Care 29:1380-2, 2006

18)              Subramanian S, Trence D:.Immunosuppressive agents: effects on glucose and lipid metabolism. Endocrinol Metab Clin North Am. 2007 Dec;36(4):891-905; vii.

19)              Moore AF, Jablonski KA, McAteer JB, et al .Diabetes Prevention Program Research Group. Extension of tyoe 2 diabetes genome-wide association scam results in the diabetes prevention programs. Diabetes.2008;57:2503-10.

20)              Kargi AY, Trence DL:HDL Cholesterol- Rationale for Targeting Cholesterol Beyond LDL-Cholesterol. Reviews of Endocrinology. 2008:22-25.

21)              Trence DL. Improving Diabetes Management and Care- Is it All About the Advancement of Pharmacotherapy. US Endocrinology. 2008;4:2-4.

22)              Rodbard HW, Trence DL, Mechanick JI. Should the Recommendation of the American Association of Clinical Endocrinologists for a Hemoglobin A1c Target of 6.5% be Modified? A Critical Reappraisal of Recent Studies of Intensive Glycemic Control. Endocr Practice 2008;14:791-795.

23)               Vendetti EM, Bray GA, Carrion-Petersen ML, et al Diabetes Prevention Program Research Group. First versus repeat teratment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes (Lond). 2008;32:1537-44.

24)              Wadden TA, West DS, Neiberg R, Wing RR, RyanDH, Johnson KC, Foreyt J, Hill JO,  Trence  DL, Vitolins M for The Look AHEAD Research Group. One-Year Weight Losses in the Look AHEAD Study:Factors Associated with Success. Obesity (Silver Spring). 2009;(4):713-22. Epub 2009 Jan 29.(Awarded OUTSTANDING JOURNAL ARTICLES PUBLISHED IN OBESITY  at Obesity Society 2009 annual meeting)

25)              Vitolins MZ, Anderson AM, Delahanty L, Raynor H, Miller GD, Mobley C, Reeves R, Yamamoto M, Champagne C, Wing RR, Mayer-Davis E; Look AHEAD Research Group. Action for Health in Diabetes (Look AHEAD) trial: baseline evaluation of selected nutrients and food group intake. J Am Diet Assoc. 2009;109:1367-75

26)              Espeland MA, Bray GA, Neiberg R, Rejeski WJ, Knowler WC, Lang W, Cheskin LJ, Williamson D, Lewis CB, Wing R; Look Ahead Study Group. Describing patterns of weight changes using principal components analysis: results from the Action for Health in Diabetes (Look AHEAD) research group. Ann Epidemiol. 2009;19:701-10. Epub 2009 Jul 22

27)              Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K; Look AHEAD Research Group. Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes. Arch Intern Med. 2009;169:163-71.

28)              Evert A, Trence D, Catton S et al. Continuous glucose monitoring technology for personal use: an educational program that educates and supportr the patient. Diabetes Educ. 2009 Jul-Aug;35(4):565-7, 571-3, 577-80.

29)              Mount DL, Feeney P, Fabricatore AN, et al; Look AHEAD and ACCORD Research Groups. Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials. Clin Trials. 2009; 6:416-29.

30)              Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Program  Lancet. 2009;374:1677-86. 

31)              Mechanick, JI, Bloomgarden ZT, Camacho PM, Cobin R, Garber AJ, Garber JR, Gharib H, Petak SM, Rodbard HW, Trence DL. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines - 2010 update. Endocr Pract. 2010; 2:270-83.

32)               Gary-Webb TL, Baptiste-Roberts K, Pham L, et al Look AHEAD Research Group. Neighborhood and weight-related health behaviors in the Look AHEAD (Action for Health in Diabetes) study.BMC Public Health. 2010;10:312

33)              Obika M, Trence DL. Comparison of type 2 diabetes care in US and in Japan. Endocr Pract. 2010 Mar 29:10-13.

34)               Rubin RR, MA Y, Peyrot M, et al Diabetes Prevention Program Research Group Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.Diabetes Care. 2010 Dec;33(12):2549-51.

35)              Look Ahead Research Group, Wing RR. Lomg-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus four-year results of the Look AHEAD trial. Arch Intern Med 2010;170:1566-75.

36)              Foy CG, Lewis CE, Hairston KG, et al Look AHEAD Research Group.Intensive lifestyle intervention improves funstion among obese adults with knee pain: findings from the Look AHEAD trial Obesity (Silver Spring). 2011;19:83-93.

37)              Odegard PS, Janci MM, Foeppel MP, Beach JR, Trence DL. Prevalence and correlates of dietary supplement use in individuals with diabetes mellitus at an an academic diabetes care clinic. Diabetes Educ 2011;37: 419-25.

38)              Kim C, Edelstein SL, Crandall JP, et al, Diabetes Prevention Program Research Group. Menopause and the risk of diabetes in the Diabetes Prevention Program. Menopause 2011; 18:857-68.

39)               Wadden TA,Neiberg RH, Wing RR, et al Look AHEAD Research Group. Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Springs) 2011;19:1987-98.

40)              McCaffery JM, Jablonski KA, Franks PW, et al, Diabetes Prevention Program Research Group. TCF7L2 polymorphism, weight loss, and proinsulin insulin ratio in the Diabetes Prevention Program. PLoS One 2011;6:e21518.

41)    Unick JL, Beavers D, Jakicic JM, et al, Look AHEAD Research Group. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care 2011;34:2152-7.

42)    Trence DL, Hirsch IB. Motherhood, Apple Pie, HbA1c, and the DCCT. Endocr Pract 2012; 18:78-84.

43)   Tylee T, Trence DL. Glycemic Variability: Looking Beyond the A1C. Diabetes Spectrum 2012; 25:149-153.

44)               Bergenstal, R, Bode B, Tamler R, Trence DL, et al. Advanced Meter Features Improve   Post-prandial and Paired Self-monitoring of Blood Glucose in Individuals With Diabetes: Results of the Actions With the CONTOUR® Blood Glucose Meter and Behaviors in Frequent Testers (ACT) Study". Diabetes Technol Ther. 2012 ;14:851-7.

45)   Delahanty LM, Pan Q, Jablonski KA, Watson KE, McCaffery JM, Shuldiner A, Kahn SE, Knowler WC, Florez JC, Franks PW; Diabetes Prevention Program Research Group Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program.Diabetes Care. 2012 Feb;35(2):363-6.

46)  Mount DL, Davis C, Kennedy B, Raatz S, Dotson K, Gary-Webb TL, Thomas S, Johnson KC, Espeland MA; Look AHEAD Research Group. Factors influencing enrollment of African Americans in the Look AHEAD trial. Clin Trials. 2012 Feb;9(1):80-9.

47)   Faulconbridge LF, Wadden TA, Rubin RR, Wing RR, Walkup MP, Fabricatore AN, Coday M, Van Dorsten B, Mount DL, Ewing LJ; Look AHEAD Research Group One-year changes in symptoms of depression and weight in overweight/obese individuals with type 2 diabetes in the Look AHEAD study. Obesity (Silver Spring). 2012 Apr;20(4):783-93

48)    Gary-Webb TL, Baptiste-Roberts K, Pham L, Wesche-Thobaben J, Patricio J, Pi-Sunyer FX, Brown AF, Jones-Corneille L, Brancati FL; Look AHEAD Research Group Neighborhood socioeconomic status, depression, and health status in the Look AHEAD (Action for Health in Diabetes) study.BMC Public Health. 2011 May 19;11:349.

49)   Peter I, McCaffery JM, Kelley-Hedgepeth A, Hakonarson H, Reis S, Wagenknecht LE, Kopin AS, Huggins GS; Genetics Subgroup of the Look AHEAD Study. Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Obesity (Silver Spring). 2012 Aug;20(8):1675-82

50)   Brancati FL, Evans M, Furberg CD, Geller N, Haffner S, Kahn SE, Kaufmann PG, Lewis CE, Nathan DM, Pitt B, Safford MM; Look AHEAD Study Group. Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study. Clin Trials. 2012 Feb;9(1):113-24.

51)    Schwartz AV, Johnson KC, Kahn SE, Shepherd JA, Nevitt MC, Peters AL, Walkup MP, Hodges A, Williams CC, Bray GA; Look AHEAD Research Group.Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial. J Bone Miner Res. 2012 Mar;27(3):619-27

52)    Rejeski WJ, Ip EH, Bertoni AG, Bray GA, Evans G, Gregg EW, Zhang Q; Look AHEAD Research Group. Lifestyle change and mobility in obese adults with type 2 diabetes.N Engl J Med. 2012 Mar 29;366(13):1209-17


53)    McCaffery JM, Papandonatos GD, Peter I, Huggins GS, Raynor HA, Delahanty LM, Cheskin LJ, Balasubramanyam A, Wagenknecht LE, Wing RR; Genetic Subgroup of Look AHEAD; Look AHEAD Research Group. Obesity susceptibility loci and dietary intake in the Look AHEAD Trial. Am J Clin Nutr. 2012 Jun;95(6):1477-86

54)   Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012 Jun 16;379(9833):2243-51

55)    ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012 Jul 26;367(4):309-18.

56)   ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012 Jul 26;367(4):319-28.

57)    Florez JC, Jablonski KA, Taylor A, Mather K, Horton E, White NH, Barrett-Connor E, Knowler WC, Shuldiner AR, Pollin TI; Diabetes Prevention Program Research Group.The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program. Diabetes Care. 2012 Sep;35(9):1864-7.

58)    Diabetes Prevention Program Outcomes Study Research Group, Orchard TJ, Temprosa M, Barrett-Connor E, Fowler SE, Goldberg RB, Mather KJ, Marcovina SM, Montez M, Ratner RE, Saudek CD, Sherif H, Watson KE. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med. 2013 Jan;30(1):46-55.

59)   Pollin TI, Isakova T, Jablonski KA, de Bakker PI, Taylor A, McAteer J, Pan Q, Horton ES, Delahanty LM, Altshuler D, Shuldiner AR, Goldberg RB, Florez JC, Franks PW; Diabetes Prevention Program Research Group. Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program. PLoS Genet. 2012;8(8):e1002895

60)    Belalcazar LM, Lang W, Haffner SM, Hoogeveen RC, Pi-Sunyer FX, Schwenke DC, Balasubramanyam A, Tracy RP, Kriska AP, Ballantyne CM; Look AHEAD Research Group. Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study.J Lipid Res. 2012 Dec;53(12):2726-33

61)    Florez JC, Jablonski KA, McAteer JB, Franks PW, Mason CC, Mather K, Horton E, Goldberg R, Dabelea D, Kahn SE, Arakaki RF, Shuldiner AR, Knowler WC; Diabetes Prevention Program Research Group. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.PLoS One. 2012;7(9):e44424.

62)    Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA; T1D Exchange Clinic Network.The T1D Exchange clinic registry.J Clin Endocrinol Metab. 2012 Dec;97(12):4383-9.

63)    Christophi CA, Resnick HE, Ratner RE, Temprosa M, Fowler S, Knowler WC, Shamoon H, Barrett-Connor E, Kahn SE; Diabetes Prevention Program Research Group.Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults. J Diabetes Complications. 2013 Mar-Apr;27(2):150-7.

64)    Ribisl PM, Gaussoin SA, Lang W, Bahnson J, Connelly SA, Horton ES, Jakicic JM, Killean T, Kitzman DW, Knowler WC, Stewart KJ; Look AHEAD Research Group. Lifestyle intervention improves heart rate recovery from exercise in adults with type 2 diabetes: results from the Look AHEAD study. J Obes. 2012;2012:3091-96.

65)    Unick JL, Beavers D, Bond DS, Clark JM, Jakicic JM, Kitabchi AE, Knowler WC, Wadden TA, Wagenknecht LE, Wing RR; Look AHEAD Research Group.The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med. 2013 Mar;126(3):236-42.

66)    Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM, Quinn M, Tamborlane WV, Woerner SE; T1D Exchange Clinic Network.Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines.Diabetes Care. 2013 Jul;36(7):2035-7.

67)    Mechanick JI, Camacho PM, Garber AJ, Garber JR, Pessah-Pollack R, Petak SM, Tangpricha V, Trence DL American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists - 2014 Update and the AACe G4G Program.Endocr Pract. 2014 Jul 1;20(7):692-702.

68)   Unick JL, Hogan PE, Neiberg RH, Cheskin LJ, Dutton GR, Evans-Hudnall G, Jeffery R, Kitabchi AE, Nelson JA, Pi-Sunyer FX, West DS, Wing RR; Look AHEAD Research Group Evaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention.Obesity (Silver Spring). 2014 Jul;22(7):1608-16..

69).   Dabelea D, Ma Y, Knowler WC, Marcovina S, Saudek CD, Arakaki R, White NH, Kahn SE, Orchard TJ, Goldberg R, Palmer J, Hamman RF; Diabetes Prevention Program Research Group. Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program. Diabet Med. 2014 Sep;31(9):1064-8.

70) Walford GA, Ma Y, Christophi CA, Goldberg RB, Jarolim P, Horton E, Mather KJ, Barrett-Connor E, Davis J, Florez JC, Wang TJ; Diabetes Prevention Program Research Group. Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program. Diabetologia. 2014 May;57(5):935-9.

71) Venditti EM, Wylie-Rosett J, Delahanty LM, Mele L, Hoskin MA, Edelstein SL; Diabetes Prevention Program Research Group.Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence. Int J Behav Nutr Phys Act. 2014 Feb 12;11:16..

72) Franks PW, Christophi CA, Jablonski KA, Billings LK, Delahanty LM, Horton ES, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program. Diabetologia. 2014 Mar;57(3):485-90..

73) Espeland MA, Lewis CE, Bahnson J, Knowler WC, Regensteiner JG, Gaussoin SA, Beavers D, Johnson KC; Look AHEAD Research Group.Impact of weight loss on ankle-brachial index and interartery blood pressures.Obesity (Silver Spring). 2014 Apr;22(4):1032-41.

74) McCaffery JM, Papandonatos GD, Huggins GS, Peter I, Erar B, Kahn SE, Knowler WC, Lipkin EW, Kitabchi AE, Wagenknecht LE, Wing RR; Genetic Subgroup of Look AHEAD; Look AHEAD Research Group.Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial.Hum Hered. 2013;75(2-4):160-74.

75) Campbell MS, Schatz DA, Chen V, Wong JC, Steck A, Tamborlane WV, Smith J, Beck RW, Cengiz E, Laffel LM, Miller KM, Haller MJ; T1D Exchange Clinic Network.A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience. Pediatr Diabetes. 2014 Mar;15(2):110-7. .

76) Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ.Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145-54.

77) Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, Bergenstal RM, Harris B, Dubose SN, Miller KM, Beck RW; T1D Exchange Clinic Network.Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry.J Clin Endocrinol Metab. 2013 Aug;98(8):3411-9.

78) Marrero D, Pan Q, Barrett-Connor E, de Groot M, Zhang P, Percy C, Florez H, Ackermann R, Montez M, Rubin RR; DPPOS Research Group.Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study.Qual Life Res. 2014 Feb;23(1):75-88.

*79) Stowell SA, Miller SC, Fonseca V, Trence D, Berry CA, Blum J. Continuing medical education for promoting shared medical visits in diabetes care. Clin Diabetes. 2015 Jan;33::28-31.

80) Lavernia F, Kushner P, Trence D, Rice D, Dailey G, Kuritzky L Recognizing and minimizing hypoglycemia: The need for individualized care. Postgrad Med. 2015 Sep 10:1-7.

81)Raynor HA, Anderson AM, Miller GD, Reeves R, Delahanty LM, Vitolins MZ, Harper P, Mobley C, Konersman K, Mayer-Davis E; Look AHEAD Research Group. Partial Meal Espeland MA, Probstfield J, Hire D, Redmon JB, Evans GW, Coday M, Lewis CE, Johnson KC, Wilmoth S, Bahnson J, Dulin MF, Green JB, Knowler WC, Kitabchi A, Murillo AL, Osei K, Rehman SU, Cushman WC; Look AHEAD Research Group; ACCORD Study Group. Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.Am J Hypertens. 2015 Aug;28(8):995-1009.eplacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial.J Acad Nutr Diet. 2015 May;115(5):731-42

82) Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH; T1D Exchange Clinic Network. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015 Mar;135(3):424-34

83) Aroda VR, Christophi CA, Edelstein SL, Zhang P, Herman WH, Barrett-Connor E, Delahanty LM, Montez MG, Ackermann RT, Zhuo X, Knowler WC, Ratner RE; Diabetes Prevention Program Research Group. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015 Apr;100(4):1646-53

84) Pownall HJ, Bray GA, Wagenknecht LE, Walkup MP, Heshka S, Hubbard VS, Hill J, Kahn SE, Nathan DM, Schwartz AV, Johnson KC; Look AHEAD Research Group.Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the look AHEAD study.Obesity (Silver Spring). 2015 Mar;23(3):565-72

85) Marrero DG, Ma Y, de Groot M, Horton ES, Price DW, Barrett-Connor E, Carnethon MR, Knowler WC; Diabetes Prevention Program Research Group. Depressive symptoms, antidepressant medication use, and new onset of diabetes in participants of the diabetes prevention program and the diabetes prevention program outcomes study. Psychosom Med. 2015 Apr;77(3):303-10.

86) Belalcazar LM, Lang W, Haffner SM, Schwenke DC, Kriska A, Balasubramanyam A, Hoogeveen RC, Pi-Sunyer FX, Tracy RP, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Research Group. Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD. Diabetes Care. 2015 Aug;38(8):1544-50

87) Unick JL, Neiberg RH, Hogan PE, Cheskin LJ, Dutton GR, Jeffery R, Nelson JA, Pi-Sunyer X, West DS, Wing RR; Look AHEAD Research Group.Weight change in the first 2 months of a lifestyle intervention predicts weight changes 8 years later. Obesity (Silver Spring). 2015 Jul;23(7):1353-6

88) DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA, Schwab KO, Holl RW, Hofer SE, Maahs DM; Type 1 Diabetes Exchange Clinic Network and Diabetes Prospective Follow-up Registry. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr. 2015 Sep;167(3):627-32

89)  McCaffery JM, Papandonatos GD, Faulconbridge LF, Erar B, Peter I, Wagenknecht LE, Pajewski NM, Anderson A, Wadden TA, Wing RR; Look AHEAD Research Group.Genetic Predictors of Depressive Symptoms in the Look AHEAD Trial. Psychosom Med. 2015 Nov-Dec;77(9):982-92 .

*90) Look AHEAD Research Group, Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Clark JM, Coday M, Curtis JM, Egan C, Evans M, Foreyt J, Foster G, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.  Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921.

91) Lee B, Trence D, Inzucchi S, Lin J, Haimowitz S, Wilkerson E, Williams C, Mosier M, Dex T. Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care. Diabetes Ther 2016; 7: 473-81.

92) Askew RL, Cook KF, Keefe FJ, Nowinski CJ, Cella D, Revicki DA, Morgan DeWitt EM,

         Michaud K, Trence DL, Antmann D. A PROMIS Measure of Neuropathic Pain Quality.                  

        Value in Health 2016; 19: 623-30.

93) Craig ME, Prinz N, Boyle CT, Campbell FM, Jones TW, Hofer SE, Simmons JH, Holman N, Tham E, Fröhlich-Reiterer E, DuBose S, Thornton H, King B, Maahs DM, Holl RW, Warner JT; Australasian Diabetes Data Network (ADDN); T1D Exchange Clinic Network (T1DX); National Paediatric Diabetes Audit (NPDA) and the Royal College of Paediatrics and Child Health; Prospective Diabetes Follow-up Registry (DPV) initiative.Prevalence of Celiac Disease in 52,721 Youth With Type 1 Diabetes: International Comparison Across Three Continents.Diabetes Care. 2017 Aug;40(8):1034-1040.

*94)  Vinik AI, Camacho P, Reddy S, Valencia WM, Trence D, Matsumoto AM, Morley JE.Aging, Diabetes, And Falls. Endocr Pract. 2017 Sep;23(9):1117-1139

*95)  Mechanick JI, Pessah-Pollack R, Camacho P, Correa R, Figaro MK, Garber JR, Jasim S, Pantalone KM, Trence D, Upala S American Association of Clinical Endocrinologists and American College of Endocrinology Protocol for Standardized Production of Clinical Practice Guidelines, Algorithms, and Checklists - 2017 Update. Endocr Pract. 2017 Aug;23(8):1006-1021

96) Ahmad I, Trence D. Art and the Endocrinology Trainee. Endocr Pract. 2017 Nov;23(11):1350-1353.


Book Chapters:

1)              Trence DL, Hirsch IB:  Diabetic ketoacidosis and HHS.  In: Conn's Current Therapies, Eds. Rakel and Pope.  Elsevier Saunders, Philadelphia, pp 678-681, 2005.

2)              Trence DL, Arnold M. Hyperglycemia In: The Art and Science of Diabetes Self-Management Education. Eds Mensing and Halstenson. American Association of Diabetes Educators, Chicago, pp 163-185, 2006

3)              Trence DL, Pommer W. Management of the Diabetic Patient with Chronic Kidney Disease. In:  Comprehensive Clinical Nephrology, 4th edition, Eds: Floege, Johnson, Feehally.  Mosby, Inc/ Elsevier, Philadelphia. pp 385-391, 2010


4)     Trence DL. Hyperglycemia In The Art and Science of Diabetes Self-Management Education. 2nd edition Eds Mensing and Halstenson. American Association of Diabetes Educators, American Association of Diabetes Educators, Chicago, pp 577-602, 2011

5)      Trence DL. Hyperglycemia. In  The Art and Science of Diabetes Self-Management Education. 3rd edition Eds Mensing, Cornell and Halstenson. American Association of Diabetes Educators, Chicago, - pp 635-662, 2014

6)      Trence DL,Hirsch IB.Insulin pumps In International Textbook of Diabetes Mellitus, 4th Edition Eds: DeFronzo, Ferrannini, Zimmet and Alberti. Wiley-Blackwell pp 745-75, 2015

7)              Trence DL. Hyperglycemia. In  The Art and Science of Diabetes Self-Management Education.Eds Cornell,Halstenson and Miller American Association of Diabetes Educators, Chicago, 4th edition- pp 611-636, 2017



Published books:

1)              Hirsch IB, Trence DL:  Optimizing Diabetes Care for the Practitioner.  Lippincott, Willliams, Wilkins, Philadelphia, pp 1-180, 2003.


Other Publications:

1)              Mensing C, Harvey L, Trence DL:  Diabetes Education Program Instructional Guide Ed: Group Health Education Department, Minneapolis, Minnesota, 1986.



1)              Will TE, Trence DL, Mensing CR, et al:  Prediction of blood glucose control in an adult population utilizing psychometric and demographic variables.  Diabetes, May 1990.

2)              Trence DL, Will TE, Mensing CR, et al:  Differences in occurrence of depression among diabetics versus other chronic disease patients.  Diabetes, May 1990.


Poster presentations:

1)              Kelly JL, Hirsch IB, Trence DL:  Rapid decrease in clinically significant hypoglycemia with insulin glargine.  American Diabetes Association Scientific Sessions, June 2002.

2)              Hagopian WA, Holder C, Brantley M, Hui P, Robitaille A, Gallinger S, Stevens J, Broyles F, Trence D, Robertson RP, Lewis V, Failor A, Capell P, Hirsch IB:  Immunogenetic testing successfully identifies diabetes type in insulin-treated diabetes.  American Diabetes Association, June 2002.

3)              Page ST, Trence DL:  Complications of treating PCOS:  Hepatic adenomas revisited.  American Association of Clinical Endocrinologists Annual Meeting, April 2004.

4)              Beach JR, Sonoda JM, Trence DL. Impact of 24-hour ambulatory blood pressure monitoring in guiding anti-hypertensive therapy:  Experience in patients with diabetes having significant pre-existing prescriptive burden.  American Diabetes Association Scientific Sessions, June 2004.

5)              Irwig, M, Trence DL:  Spontaneous remission of diabetes mellitus, type 1. American Association of Clinical Endocrinologists Annual Meeting, May, 2005

6)              Chiu H, Trence DL:  Diabetic pseudohernia-postulated diagnostic work-up.  American Association of Clinical Endocrinologists Annual Meeting, May, 2005.

7)              Udayasankar J, Trence DL: Vitamin D and Glycemic Status in Diabetes Mellitus. American Association of Clinical Endcrinologists Annual Meeting  2007

8)              Trence DL, Beach JR, Janci M, Odegard P: Use of Non-prescriptive Therapies by Individuals with Diabetes (DM). American Diabetes Association Annual Meeting 2007

9)              Marina A, Trence DL. Is Diabetes Mellitus Really Cured by Gastric Bypass Surgery? American Association of Clinical Endocrinologists Annual Meeting, April, 2010

10)              Bergenstal RM, Bode B, Tamler R, Trence DL, Fullam J, Stenger P, Schachner HC, Pardo S, Brown T , Jackson R. ACT: Actions with the CONTOUR Blood Glucose Meter and   Behaviors in Frequent Testers. EASD, Stockholm, September 2010

11)              Trence, DL, Bergenstal, RM, Bode BW; Tamler R, Khakpour D, Monk AM, Hosey R, Brown, T, Patricia Stenger, Schachner HC, Fullam J, Pardo S, Kohut T, Fisher WA. Subanalyses of SMBG in the ACT (Actions with the Contour Blood Glucose Meter and Behaviours in Frequent  Testers) Trial. AACE Annual Meeting, San Diego, April 2011

12)               Tylee T, Trence DL. Systemic Vasculitis Presenting with Bilateral Adrenal Enlargement and Adrenal Insufficiency. Endocrine Society. Boston. 2011

13)               Chukwu, J, Hirsch IB, Trence DL. Frequency of Inability to Use A1c as Marker if Glycemic Control in an Academic Diabetes Center ADA Philadelphia 2012

14)               Trence DL, Hirsch IB, Evert A, et al   Detailed One Year Time Analysis of Utilization in an Academic Diabetes Clinic- American Diabetes Association Annual Meeting Philadelphia 2012

15)               Chukwu, J, Hirsch IB, Trence, DL. Incretin Use in the Insulin Resistant Endocrine Society Houston, 2012

16)    Berkseth KE, Trence DL, Hirsch IB. Association of Fructosamine with Capillary Blood Glucose in Patients with Diabetes Endo Society, San Francisco, June 2013

17)    Duran LA, Pichler R, Hirsch IB, Trence DL. Is There Value to a Combined Diabetes-Renal Clinic in Diabetes Kidney Disease? Endo Society, San Francisco, June 2013

18)    Koh E, Trence DL. Why Technology Fades Endocrine Society San Diego, March 2015

19)    Weaver K, Trence DL. When Translational Medicine Hits Reality: The Hybrid Closed-Loop Insulin Delivery System in Real-life Patient Experience AACE, Boston, May 2018